Genialis Teams With Slovenian Bioinformatics Group to Develop Precision Medicine Tools

Mar 18, 2021

|

NEW YORK – Genialis said Thursday that it has reached a sponsored research agreement with BioLab, the bioinformatics laboratory at the University of Ljubljana in Slovenia, to create new algorithms and computing methods for choosing therapeutic options for patients based on their disease subtype.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Early Trial Responses

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Hurdles to Genomic Surveillance

Nature News writes that viral genomic surveillance in the US faces systemic issues.

Boosts Requested

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

PLOS Papers on Chronic Pain, Indigenous Populations in Mexico, SARS-CoV-2 Mutations

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.

Menu

Genialis Teams With Slovenian Bioinformatics Group to Develop Precision Medicine Tools

To read the full story....

Breaking News

Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor

Proteomic Study of SARS-CoV-2, SARS-CoV Infections Points to Potential Drug Targets

HudsonAlpha Health Alliance, Auburn University Form Genetic Testing Partnership

Amazon to Give Out $12M Under Next Phase of AWS Diagnostics Development Initiative

Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings

Top Five Articles on GenomeWeb Last Week: Invitae, Cancer, Illumina, and More

The Scan

Early Trial Responses

Hurdles to Genomic Surveillance

Boosts Requested

PLOS Papers on Chronic Pain, Indigenous Populations in Mexico, SARS-CoV-2 Mutations

What's Popular?

DiaSorin to Acquire Luminex for $1.8B

Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings

10x Genomics, Bio-Rad Laboratories Subsidiary Celsee Headed to Trial in Single-Cell IP Suit

Genomenon, Limbus Medical to Integrate Technologies for Clinical Variant Interpretation

People in the News: New Appointments at Mission Bio, Akoya Biosciences, Micronoma, More

Sponsorships